Aethlon Medical, Inc.
NASDAQ: AEMD0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- James Frakes
- Employees
- 14
- Headquarters
- San Diego, United States
- IPO year
- 1999
- Market cap
- $928.8K
- Website
- https://www.aethlonmedical.com
Loading AEMD…
Loading profile data…Frequently asked questions about AEMD
What does Aethlon Medical, Inc. (AEMD) do?
Aethlon Medical, Inc. operates as a medical technology enterprise, dedicated to innovating solutions for the diagnosis and treatment of life-threatening and organ-jeopardizing diseases within the United States. Central to its pipeline is the Aethlon Hemopurifier, a clinical-stage immunotherapeutic device. This device is engineered to clear the h...
Where does AEMD trade?
Aethlon Medical, Inc. (AEMD) trades on the NASDAQ Capital Market.
What sector is AEMD in?
Aethlon Medical, Inc. (AEMD) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Aethlon Medical, Inc.?
James Frakes is the chief executive officer of Aethlon Medical, Inc. (AEMD).
Where is Aethlon Medical, Inc. headquartered?
Aethlon Medical, Inc. is headquartered in United States.
Does AEMD pay a dividend?
Aethlon Medical, Inc. (AEMD) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AEMD go public?
Aethlon Medical, Inc. (AEMD) completed its initial public offering in 1999.